type here...

CATEGORIES

Press Release

LATEST

1234...12Page 3 of 12

TRENDING

EDITORS CHOICE

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Medika Life -
SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.

Coronavirus: FDA Authorizes First Point-of-Care Antibody Test

Medika Life -
The Assure COVID-19 IgG/IgM Rapid Test Device is currently the only FDA authorized COVID-19 POC serology test and is available by prescription only.

South University Announces New MSPA Program at West Palm Beach Campus

Medika Life -
South University is proud to announce the launch of a new Master of Science in Physician Assistant (“MSPA”) program at the West Palm Beach campus located in Royal Palm Beach, Florida

Mindray’s New POC Ultrasound System Redefines What’s Possible

Medika Life -
The ME8 System's main unit is one of the lightest and thinnest laptop-based ultrasound machines in the industry.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories